Select Your Region
Global
A clinical trial to observe patients with a diagnosis of COVID-19, who have previously taken part in an AT-527 COVID-19 clinical trial
A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study
- Doenças Infecciosas
- Pneumonia por COVID-19
- COVID-19
Observe que o status de recrutamento do estudo em seu centro pode ser diferente do status geral do estudo porque alguns centros de estudo podem recrutar mais cedo do que outros.
Status do estudo:
Terminado
Este estudo é realizado em
Cidades
- Distrito Federal
- Paraná
- Pernambuco
- São Paulo
Identificador de estudo:
NCT05059080 2021-000627-12 CV43140
As informações abaixo se origina a partir do site ClinicalTrials.gov publicamente disponível e não foi modificado.
Resumo do Estudo
This study will evaluate the long-term sequelae of COVID-19 in patients diagnosed with COVID-19 who previously enrolled in a RO7496998 (AT-527) study (i.e. parent study NCT04889040 [CV43043]), for approximately 6 months after the end of the parent study.
Hoffmann-La Roche
Patrocinador
N/A
Fase
NCT05059080, CV43140, 2021-000627-12
Identificador de estudo
COVID-19, Long COVID
Condição
Título
A Multicenter, Observational, 6-Month Follow-up Study of Patients With COVID-19 Previously Enrolled in a RO7496998 (AT-527) Study
Critérios de elegibilidade
Todos
Gênero
≥12 Anos
Idade
Não
Voluntários Saudáveis
Critérios de Inclusão
- Participant was diagnosed with COVID-19 and enrolled in a Phase III RO7496998 (AT-527) COVID-19 study
Critérios de Exclusão
- Participation in an interventional study at the time of enrollment or plans to enroll in an interventional study during this study.
- Any serious medical condition or abnormality of clinical laboratory tests that, in the investigator's judgment, precludes the patient's safe participation in and completion of the study
For the latest version of this information please go to www.forpatients.roche.com